Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The development of immunotherapy for cancer, such as synthetic peptide-based vaccines, relies heavily on the identification of appropriate epitopes capable of eliciting antitumor T-cell responses. We have used a combination of computer-based algorithms to predict peptide sequences from prostate-specific membrane antigen (PSMA) capable of stimulating in vitro CTLs restricted by the HLA-A2 MHC molecule. Four of the five peptides that were predicted by these algorithms were capable of inducing antigen-specific CTLs that killed target cells that were pulsed exogenously with the corresponding peptides. However, only one of the four peptides, PSMA27, induced CTLs that were effective at recognizing prostate tumor cells expressing the HLA-A2 and PSMA molecules. These results underline the importance of demonstrating antitumor reactivity of peptide-induced CTLs for the selection of epitopes destined to become immunotherapeutic for prostate cancer.

Original languageEnglish (US)
Pages (from-to)5807-5812
Number of pages6
JournalCancer Research
Volume62
Issue number20
StatePublished - Oct 15 2002

Fingerprint

Cytotoxic T-Lymphocytes
Prostate
Peptides
HLA-A2 Antigen
Neoplasms
Epitopes
Synthetic Vaccines
Subunit Vaccines
Immunotherapy
Prostatic Neoplasms
human glutamate carboxypeptidase II
T-Lymphocytes
Antigens

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen. / Lu, Jun; Celis, Esteban.

In: Cancer Research, Vol. 62, No. 20, 15.10.2002, p. 5807-5812.

Research output: Contribution to journalArticle

@article{59c117b86825400095fe3f20b342901d,
title = "Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen",
abstract = "The development of immunotherapy for cancer, such as synthetic peptide-based vaccines, relies heavily on the identification of appropriate epitopes capable of eliciting antitumor T-cell responses. We have used a combination of computer-based algorithms to predict peptide sequences from prostate-specific membrane antigen (PSMA) capable of stimulating in vitro CTLs restricted by the HLA-A2 MHC molecule. Four of the five peptides that were predicted by these algorithms were capable of inducing antigen-specific CTLs that killed target cells that were pulsed exogenously with the corresponding peptides. However, only one of the four peptides, PSMA27, induced CTLs that were effective at recognizing prostate tumor cells expressing the HLA-A2 and PSMA molecules. These results underline the importance of demonstrating antitumor reactivity of peptide-induced CTLs for the selection of epitopes destined to become immunotherapeutic for prostate cancer.",
author = "Jun Lu and Esteban Celis",
year = "2002",
month = "10",
day = "15",
language = "English (US)",
volume = "62",
pages = "5807--5812",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen

AU - Lu, Jun

AU - Celis, Esteban

PY - 2002/10/15

Y1 - 2002/10/15

N2 - The development of immunotherapy for cancer, such as synthetic peptide-based vaccines, relies heavily on the identification of appropriate epitopes capable of eliciting antitumor T-cell responses. We have used a combination of computer-based algorithms to predict peptide sequences from prostate-specific membrane antigen (PSMA) capable of stimulating in vitro CTLs restricted by the HLA-A2 MHC molecule. Four of the five peptides that were predicted by these algorithms were capable of inducing antigen-specific CTLs that killed target cells that were pulsed exogenously with the corresponding peptides. However, only one of the four peptides, PSMA27, induced CTLs that were effective at recognizing prostate tumor cells expressing the HLA-A2 and PSMA molecules. These results underline the importance of demonstrating antitumor reactivity of peptide-induced CTLs for the selection of epitopes destined to become immunotherapeutic for prostate cancer.

AB - The development of immunotherapy for cancer, such as synthetic peptide-based vaccines, relies heavily on the identification of appropriate epitopes capable of eliciting antitumor T-cell responses. We have used a combination of computer-based algorithms to predict peptide sequences from prostate-specific membrane antigen (PSMA) capable of stimulating in vitro CTLs restricted by the HLA-A2 MHC molecule. Four of the five peptides that were predicted by these algorithms were capable of inducing antigen-specific CTLs that killed target cells that were pulsed exogenously with the corresponding peptides. However, only one of the four peptides, PSMA27, induced CTLs that were effective at recognizing prostate tumor cells expressing the HLA-A2 and PSMA molecules. These results underline the importance of demonstrating antitumor reactivity of peptide-induced CTLs for the selection of epitopes destined to become immunotherapeutic for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0037108840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037108840&partnerID=8YFLogxK

M3 - Article

C2 - 12384542

AN - SCOPUS:0037108840

VL - 62

SP - 5807

EP - 5812

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 20

ER -